Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of SYMQY will - over the next 2 Weeks and hit - by . In that time frame, SYMQY's share price is expected to range between - and -.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No Data | |||||||||||||||||||
SYMQY shares remained flat 0 in Wednesday, August 19, 2026's trading session, starting and closing at a previous close of $0.56 to move at $0.56. The stock demonstrated notable intraday movement (see SYMQY's key stats for a full breakdown), fluctuating between $0.56 and $0.66, a +18.35% trading range. While recent weeks have seen some volatility, SYMQY has managed to secure a -43.51% drop over the past 2 weeks. The neutral price movement was accompanied by increased trading volume, with approximately 1K shares changing hands, 999 more than the previous session. This amounted to $557.90 in total market activity.
Will SYMQY Continue Its Trend?
According to analyst ratings and projections for SYMQY, SymBio Pharmaceuticals Limited shares are anticipated to remain stable by -, potentially reaching - per share by January 1, 1970. Short-term technical indicators for SYMQY currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 29 negative trading days within the past 30 sessions. Based on the SYMQY stock forecast, now is not the best time to buy SYMQY stock because its current trading price is - our predicted value, hinting at a possible . For deeper insights, view our sentiment analysis on SYMQY covering social and institutional perspectives.
SYMQY Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into SYMQY's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 0.00% to 0.20%) suggest the stock is in a strong bearish momentum phase. The 50-day RSI, at 9.32%, hints at a potential medium-term rebound. Meanwhile, the 100-day RSI, at 19.63%, reflects strong bullish momentum over the long term. Insights into SYMQY's shareholder base show how institutional investors are positioning themselves during these momentum shifts

